The U.S. Autoimmune Disease Therapeutics Market is projected to grow from USD 32.18 Billion in 2025 to USD 54.72 Billion by 2035, while Europe is expected to expand from USD 24.32 Billion to USD 41.66 Billion, driven by rising biologics adoption, FDA and EMA approvals, precision medicine, biosimilars, and increasing prevalence of rheumatoid arthritis, multiple sclerosis, lupus, and inflammatory bowel disease.
The U.S. Autoimmune Disease Therapeutics Market is projected to grow from USD 32.18 Billion in 2025 to USD 54.72 Billion by 2035, while Europe is expected to expand from USD 24.32 Billion to USD 41.66 Billion, driven by rising biologics adoption, FDA and EMA approvals, precision medicine, biosimilars, and increasing prevalence of rheumatoid arthritis, multiple sclerosis, lupus, and inflammatory bowel disease.